Global 1, 1' Carbonyldiimidazole Market Strategic Research Report

Scope of the Report

The global 1, 1' Carbonyldiimidazole market size is predicted to grow from US$ 22.08 million in 2025 to US$ 26.64 million in 2032; it is expected to grow at a CAGR of 3.3% from 2026 to 2032.

1,1′-Carbonyldiimidazole (CDI; CAS 530-62-1, molecular formula C₇H₆N₄O) is a versatile reagent used in numerous chemical synthesis processes as a safer equivalent to phosgene. It functions as an efficient coupling and activation agent in the formation of amides, esters, and carbonyl compounds. Due to its stability and reliable performance, it is widely applied in pharmaceutical and industrial production, making it a valuable intermediate in fine and specialty chemical manufacturing.

In 2025, global production of 1,1′-Carbonyldiimidazole (CDI) reached approximately 1,328 tons, with an average global market price of around US$ 17/kg. The gross profit margin is approximately 20%-30%.

Gradual growth, niche scale: CDI demand typically expands at a moderate pace because it is tied to specific synthesis routes (pharma intermediates, peptides) rather than broad commodity uses.

Often campaign / make-to-order production: Many suppliers prefer to organize production by batch/order rather than large-scale upfront stockpiling.

Substitution competition is real in amide/peptide coupling: CDI competes with alternative coupling strategies and reagents (e.g., T3P, HATU in some settings) and with process designs aiming to reduce coupling-reagent usage.

Development speed varies across regions: Asia-Pacific growth is expected to be faster, led by China and India. In parallel, the market shows increasing China/India-based supply depth, supporting faster regional expansion.

Technology trend: Better yield and waste reduction via imidazole recycle loops. Patented industrial routes emphasize neutralizing the imidazole·HCl by-product and recycling imidazole back into CDI production, targeting cost reduction and more sustainable operations.

Key Questions Addressed in this Report

What is the 10-year outlook for the global 1, 1' Carbonyldiimidazole market?

What factors are driving 1, 1' Carbonyldiimidazole market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do 1, 1' Carbonyldiimidazole market opportunities vary by end market size?

How does 1, 1' Carbonyldiimidazole break out by Type, by Application?

This report presents a comprehensive overview of the global 1, 1' Carbonyldiimidazole market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Purity≥98%
• Purity＜98%

Segment by Sales Channels

• Direct Selling
• Distribution

Segment by Application

• Pharmaceuticals
• Peptide Synthesis
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global 1, 1' Carbonyldiimidazole market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pharmaceuticals, Peptide Synthesis, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact